In vitro experiments on prostate cancer cell lines (e.g., LNCaP, PC-3) will verify the regulatory effects on AR signaling pathways, assessing PSA expression, cell processes, and using siRNA to distinguish interactions. Here, AR is linked to prostate carcinoma.